Jan-Aug sales at BioMaxima up 88% as company enters Switzerland
11 years 50 weeks atpakaļ
PCZ’s drug wholesaling unit receives additional GIF permit
11 years 50 weeks atpakaļ
Bioton reports 23% rise in like-for-like sales in H1 thanks to strong insulin sales
11 years 50 weeks atpakaļ
Swissmed partners with AHP
11 years 50 weeks atpakaļ
Inno-Gene posts dynamic sales growth in Q2 as new ventures prepare to start operations
12 years 11 stundas atpakaļ
OTC market in CIS countries 2013
12 years 1 dienu atpakaļ
Ministry unveils new reimbursement lists
12 years 1 dienu atpakaļ
Ministry outlines changes to Reimbursement Act
12 years 2 weeks atpakaļ
Hebe to enter Katowice market
12 years 2 weeks atpakaļ
Biological and biosimilars drug market in Poland 2013
12 years 2 weeks atpakaļ
SUKL to apply new guidelines on examination of MA variations
12 years 2 weeks atpakaļ
Egis reports sales of €13.6m in Poland in April-June 2013
12 years 2 weeks atpakaļ
EI exits Magellan
12 years 2 weeks atpakaļ
ERROR: Tried to load source page, but remote server reported "503 Service Unavailable".
12 years 2 weeks atpakaļ
BioMaxima posts strong Q2 results, expects to complete new M&A deals in Q3
12 years 2 weeks atpakaļ
Private healthcare market in CIS countries 2013
12 years 3 weeks atpakaļ
Further increase in number of real users of Doz.pl in April 2013
12 years 4 weeks atpakaļ
Pharmena announces positive findings from 1-MNA supplement study
12 years 4 weeks atpakaļ
Swissmed to open talks with new investor as equity sale to LUX MED Group collapses
12 years 4 weeks atpakaļ
Dr. Max launches first drug under its brand name in the Czech Republic
12 years 4 weeks atpakaļ
- « pirmais
- ‹ iepriekšējais
- …
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- …
- nākamais ›
- pēdējais »